AU2002221567A1 - Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis - Google Patents

Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis

Info

Publication number
AU2002221567A1
AU2002221567A1 AU2002221567A AU2156702A AU2002221567A1 AU 2002221567 A1 AU2002221567 A1 AU 2002221567A1 AU 2002221567 A AU2002221567 A AU 2002221567A AU 2156702 A AU2156702 A AU 2156702A AU 2002221567 A1 AU2002221567 A1 AU 2002221567A1
Authority
AU
Australia
Prior art keywords
oestrogen
manufacture
composition containing
atrophic vaginitis
forthe treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221567A
Inventor
Karen Koch
Ingelise Kvorning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002221567(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2002221567A1 publication Critical patent/AU2002221567A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginits, in woman by administering weekly an amount of about 10 to 30 ug estradiol to a woman
AU2002221567A 2000-12-15 2001-12-13 Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis Abandoned AU2002221567A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200001892 2000-12-15
DKPA200001891 2000-12-15
DKPA200001890 2000-12-15
DKPA200001890 2000-12-15
DKPA200001891 2000-12-15
DKPA200001892 2000-12-15
PCT/DK2001/000824 WO2002047692A1 (en) 2000-12-15 2001-12-13 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis

Publications (1)

Publication Number Publication Date
AU2002221567A1 true AU2002221567A1 (en) 2002-06-24

Family

ID=27222474

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221567A Abandoned AU2002221567A1 (en) 2000-12-15 2001-12-13 Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis

Country Status (10)

Country Link
EP (3) EP1343508B1 (en)
JP (2) JP4851057B2 (en)
AT (1) ATE532521T1 (en)
AU (1) AU2002221567A1 (en)
CY (1) CY1112542T1 (en)
DE (2) DE10179223T1 (en)
DK (2) DK1343508T3 (en)
ES (2) ES2725774T1 (en)
PT (1) PT1343508E (en)
WO (1) WO2002047692A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1343508T3 (en) 2000-12-15 2012-02-27 Novo Nordisk Femcare Ag Use of an estrogen for the manufacture of a composition containing estrogen for the treatment of atrophic vaginitis
GT200500315A (en) * 2004-11-02 2006-06-06 SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE
EP3272333A1 (en) * 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
EP3603626A1 (en) 2018-07-31 2020-02-05 Mucosa Innovations, S.L. Composition for use in the prevention and/or treatment of the genitourinary mucosa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739558B1 (en) * 1995-10-05 1997-11-28 Innothera Lab Sa UNITAL GALENIC FORM FOR LOCAL HORMONOTHERAPY OF VAGINAL DROUGHT
EP1187618A1 (en) * 1999-06-04 2002-03-20 The General Hospital Corporation Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
DK1343508T3 (en) * 2000-12-15 2012-02-27 Novo Nordisk Femcare Ag Use of an estrogen for the manufacture of a composition containing estrogen for the treatment of atrophic vaginitis

Also Published As

Publication number Publication date
EP1343508B1 (en) 2011-11-09
ES2725774T1 (en) 2019-09-27
JP4851057B2 (en) 2012-01-11
WO2002047692A1 (en) 2002-06-20
DE20120246U1 (en) 2002-05-29
ATE532521T1 (en) 2011-11-15
DK2366395T2 (en) 2020-06-15
ES2376649T3 (en) 2012-03-15
JP2010189409A (en) 2010-09-02
EP2366395A1 (en) 2011-09-21
EP3747443A3 (en) 2021-03-03
PT1343508E (en) 2012-02-20
EP3747443A2 (en) 2020-12-09
DE10179223T1 (en) 2019-10-24
EP1343508A1 (en) 2003-09-17
DK2366395T1 (en) 2019-09-23
CY1112542T1 (en) 2015-12-09
DK1343508T3 (en) 2012-02-27
JP2004515531A (en) 2004-05-27

Similar Documents

Publication Publication Date Title
GB0001309D0 (en) Valve arrangement
RS20060348A (en) Extended use combination comprising estrogens and progestins
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
AU2556397A (en) Anti-caries oral compositions
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004779A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
BG66114B1 (en) Pharmaceutical composition with drospirenone as contraceptive
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
HUP0402142A2 (en) Composition of estrogen/gestagen combination, preparation and application thereof
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2429639A1 (en) Stable azithromycin monohydrate
IL136196A0 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
CY1112542T1 (en) USE OF A ESTROGEN FOR THE INDUSTRIAL CONSTRUCTION OF A COMPOSITION CONTAINING ESTROGEN FOR THE TREATMENT OF Atrophic Colitis
HRP20030002A2 (en) STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
UA72927C2 (en) Docetaxel-containing composition for treating hepatocellular carcinoma
NZ326345A (en) Composition containing diosgenin
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU4429801A (en) Pharmaceutical compositions including alginates
WO2003032909A3 (en) Methods of treating skin with diphosphonate derivatives
IL129267A0 (en) Treatment of urinary incontinence and compositions for use therein
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.
BG104839A (en) Chrystalline form of paroxetine
AU2802700A (en) Utilization of dienogest in high doses
MXPA05003633A (en) 2" oxo-voruscharin and derivatives thereof.